PANBELA THERAPEUTICS, INC. : Termination of a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)

Item 1.02 Termination of a Material Definitive Agreement.

On April 5, 2023, One-Two Therapeutics Assets Limited notified
Panbela Therapeutics, Inc. that One-Two is terminating the
License... | April 12, 2023

Related Keywords

Canada ,United States ,American , ,Therapeutics Assets Limited ,Cancer Prevention Pharmaceuticals Inc ,Company Press ,Securities Exchange ,Panbela Therapeutics Inc ,Material Definitive ,Two Therapeutics Assets Limited ,License Agreement ,Prevention Pharmaceuticals ,North American ,Current Report ,Securities Exchange Act ,Securities Act ,Exchange Act ,Press Release ,Page Interactive Data File ,Edgar Online ,Panbela Therapeutics ,Nc Stock Exchange ,News ,Information ,Item ,Termination ,F ,Material ,Efinitive ,Pril ,Herapeutics ,Assets ,Imited ,Hat ,Us ,Erminating Pbla Us69833w2061 ,